Clinical significance of serum carbohydrate antigen 19.9 and duke pancreatic monoclonal antigen type 2 for the prediction of hematogenous metastases in patients with pancreatic ducal adenocarcinoma
Keywords: Metastasis; Tumor marker; Recurrence; CA 19.9; DUPAN-2;